Clinical trial
Phase I Trial of Sonidegib and Pembrolizumab in Advanced Solid Tumors
NCT04007744 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Trial of Sonidegib and Pembrolizumab in Advanced Solid Tumors
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- February 13, 2020
- Completion date
- July 2, 2027
- Enrollment
- 36 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
clinical stage iii cutaneous melanoma ajcc v8, clinical stage iii gastric cancer ajcc v8, clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iv cutaneous melanoma ajcc v8, clinical stage iv gastric cancer ajcc v8, clinical stage iv gastroesophageal junction adenocarcinoma ajcc v8, locally advanced gastric adenocarcinoma, locally advanced gastroesophageal junction adenocarcinoma, locally advanced urothelial carcinoma, metastatic gastric adenocarcinoma, metastatic gastroesophageal junction adenocarcinoma, metastatic head and neck squamous cell carcinoma, metastatic lung non-small cell carcinoma, metastatic malignant solid neoplasm, metastatic melanoma, metastatic urothelial carcinoma, recurrent head and neck squamous cell carcinoma, refractory lung non-small cell carcinoma, stage iv cutaneous squamous cell carcinoma of the head and neck ajcc v8, stage iv lung cancer ajcc v8, unresectable malignant solid neoplasm, unresectable melanoma